חזרה לתוצאות החיפוש

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Acute Coronary Syndrome

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Novartis Investigative Site, Clayton, Victoria, Australia

  • Novartis Investigative Site, Montreal, Quebec, Canada

  • Novartis Investigative Site, Beijing, China, China

  • Novartis Investigative Site, Guangzhou, Guangdong, China

  • Novartis Investigative Site, Luoyang, Henan, China

  • Novartis Investigative Site, Xuzhou, Jiangsu, China

  • Novartis Investigative Site, Nanchang, Jiangxi, China

  • Novartis Investigative Site, Wenzhou, Zhejiang, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Beijing, China

  • Novartis Investigative Site, Guangzhou, China

  • Novartis Investigative Site, Guangzhou, China

  • Novartis Investigative Site, Jining, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Shanghai, China

  • Novartis Investigative Site, Tianjin, China

  • Novartis Investigative Site, Chambray-lès-Tours, France

  • Novartis Investigative Site, Montpellier, France

  • Novartis Investigative Site, Nantes, France

  • Novartis Investigative Site, Pessac, France

  • Novartis Investigative Site, Poitiers, France

  • Novartis Investigative Site, Leipzig, Saxony, Germany

  • Novartis Investigative Site, Coburg, Germany

  • Novartis Investigative Site, Erfurt, Germany

  • Novartis Investigative Site, Essen, Germany

  • Novartis Investigative Site, Hennigsdorf, Germany

  • Novartis Investigative Site, Kiel, Germany

  • Novartis Investigative Site, Hong Kong, Hong Kong, Hong Kong

  • Novartis Investigative Site, Hong Kong, Hong Kong

  • Novartis Investigative Site, Pécs, Baranya, Hungary

  • Novartis Investigative Site, Debrecen, Hajdu Bihar Megye, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Miskolc, Hungary

  • Novartis Investigative Site, Belagavi, Karnataka, India

  • Novartis Investigative Site, Mumbai, Maharashtra, India

  • Novartis Investigative Site, Nashik, Maharashtra, India

  • Novartis Investigative Site, Bikaner, Rajasthan, India

  • Novartis Investigative Site, Chikushino-shi, Fukuka, Japan

  • Novartis Investigative Site, Kitakyushu, Fukuoka, Japan

  • Novartis Investigative Site, Kamakura, Kanagawa, Japan

  • Novartis Investigative Site, Sagamihara, Kanagawa, Japan

  • Novartis Investigative Site, Bunkyo Ku, Tokyo, Japan

  • Novartis Investigative Site, Gdansk, Poland

  • Novartis Investigative Site, Krakow, Poland

  • Novartis Investigative Site, Opole, Poland

  • Novartis Investigative Site, Seoul, Seoul, South Korea

  • Novartis Investigative Site, Seoul, South Korea

  • Novartis Investigative Site, Santiago Compostela, A Coruna, Spain

  • Novartis Investigative Site, Huelva, Andalusia, Spain

  • Novartis Investigative Site, El Palmar, Murcia, Spain

  • Novartis Investigative Site, Las Palmas GC, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Madrid, Spain

  • Novartis Investigative Site, Salamanca, Spain

  • Novartis Investigative Site, Seville, Spain

  • Novartis Investigative Site, Valencia, Spain

  • Novartis Investigative Site, Bern, Switzerland

  • Novartis Investigative Site, Geneva, Switzerland

  • Novartis Investigative Site, Lucerne, Switzerland

מובילי המחקר

  • Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)פנייה לחוקר (אימייל)